New Drug Approvals in 2026 for MBC
In 2026, the FDA approved or expanded the use for several drugs for people with MBC. Read below to learn about these new approvals. 1. Gedatolisib (Revtorpyk®)...
Read MoreWhat is ctDNA Testing and How is it Used in Clinical Trials?
Participating in a trial has many possible benefits. A common question about clinical trials is whether you will be paid to participate. Read below to learn more...
Read MoreAmerican Association for Cancer Research (AACR) and American Society of Clinical Oncology (ASCO) 2026
American Association for Cancer Research (AACR) The AACR recently held its 2026 conference from April 17-22, 2026. Read below to learn about MBC-related reports...
Read MoreRecent Progress in Treating MBC that has Spread to the Brain
Several treatments are available for MBC that has spread to the brain, also called brain metastases. This is an active area of investigation in clinical trials....
Read MoreWhat to Know About the PAM Pathway (PI3K, AKT and mTOR): Currently Approved and Experimental Treatments for MBC
Gedatolisib (Revtorpyk®) is a newly approved treatment for people with hormone receptor-positive, HER2-negative MBC without a PIK3CA mutation whose cancer has...
Read MoreNew Targeted Treatment Options for Metastatic Breast Cancer: Updates on PIK3CA
There is encouraging news for people living with hormone receptor–positive, HER2 negative metastatic breast cancer. For tumors that have a specific change called...
Read MorePeer Support for Young Adults Diagnosed with MBC
Being diagnosed with metastatic breast cancer under age 40 can feel especially isolating. Peer support connects young adults with others who truly understand the...
Read MoreUsing Targeted Radiation for People with Only a Few Metastases
Some people with metastatic cancer have disease that is limited to only a few sites (oligomestatic). Researchers are studying whether using radiation on these...
Read MoreAntibody Drug Conjugates: What’s New and What to Know
Antibody-drug conjugates (ADCs) are a type of targeted therapy used to treat metastatic breast cancer (MBC). ADCs are sometimes called “smart drugs”...
Read MoreSEARCH OUR SITE
for past articles or specific information.